The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab

BACKGROUND: It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non‐small‐cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study was to evaluate body composition changes in rela...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cachexia Sarcopenia Muscle
Main Authors: Degens, Juliette H.R.J., Dingemans, Anne‐Marie C., Willemsen, Anna C.H., Gietema, Hester A., Hurkmans, Daan P., Aerts, Joachim G., Hendriks, Lizza E.L., Schols, Annemie M.W.J.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8200425/
https://ncbi.nlm.nih.gov/pubmed/33951326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12698
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares